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ABSTRAK
Latar belakang: terdapat peningkatan populasi dewasa muda dengan penyakit arteri koroner yang memiliki 
penyakit Kawasaki saat usia anak, dan dokter spesialis jantung/penyakit dalam harus siap untuk merawat 
mereka. Penyakit Kawasaki (PK) pada remaja dan dewasa masih jarang dan belum banyak dikenal, karena itu 
penting untuk mempelajari data pasien dengan mengetahui kriteria diagnostik dan pedoman pengobatan untuk 
kelompok usia ini. Penelitian ini bertujuan membandingkan profil klinis penyakit Kawasaki (PK) antara kelompok 
pasien berusia lebih dari 10 tahun (remaja) dan kurang dari 10 tahun (anak). Metode: analisis dilakukan 
pada 1150 kasus PK selama periode Januari 2003-Desember 2016. Profil klinis saat fase akut dibandingkan 
antara kelompok pasien berusia lebih dari 10 tahun dengan kurang dari 10 tahun. Hasil: dari 1150 kasus 
PK ditemukan 17 kasus PK remaja (1,5%), dengan presentasi klinis yang  lebih sering dijumpai adalah PK 
inkomplit (59%), lebih tinggi dibandingkan pada kelompok kurang dari 10 tahun (29%). Beberapa tanda klinis 
lebih sering dijumpai pada anak dibandingkan remaja, seperti konjungtivitis (85% pada <10 tahun; 65% pada 
>10 tahun), perubahan mukosa (94% vs. 77%), ruam (86% vs. 59%), dan perubahan tangan dan kaki (68% 
vs 41%). Sedangkan  tanda klinis lain lebih sering dijumpai pada remaja seperti limfadenopati servikal (82% 
vs 39%) maupun dilatasi koroner (47% vs 29%). Pada pemeriksaan laboratorium (hemoglobin, leukosit, laju 
endap darah, dan C reactive protein) tidak didapatkan perbedaan bermakna antara 2 kelompok. Kesimpulan: 
penyakit Kawasaki pada remaja memiliki profil klinis yang berbeda dengan anak-anak. Mayoritas pasien remaja 
menunjukkan PK inkomplit. Beberapa gejala klinis seperti konjungtivitis, kelainan mukosa, ruam, dan perubahan 
tangan/kaki lebih sering dijumpai pada PK kurang dari 10 tahun, sedangkan limfadenopati servikal dan  dilatasi 
koroner lebih sering ditemukan pada PK remaja. Rasio lelaki : perempuan jauh lebih tinggi pada PK remaja.
Kata kunci: penyakit Kawasaki, remaja.
ABSTRACT
Background: there is clearly growing population of young adults with potentially important coronary 
artery disease after Kawasaki disease (KD) during childhood, and cardiologist must be prepared to take care 
for them. As Kawasaki disease in adolescent and adult is rare and under-recognized, it is important to study 
data on patient presentations which may permit development of diagnostic criteria and treatment guidelines 
for this age group.This study aimed to compare the clinical profile of KD between adolescents (>10 years of 
age) and children ≤10 years. Methods: This is a cross sectional study. A total of 1150 KD cases (age 1-192 
months) during the period of January 2003-December 2016 were analyzed. The clinical profile of subjects aged 
>10 years (adolescents) and  ≤10 years (children) at acute phase of KD were compared. Results: we found 17 
cases of KD in adolescents among 1150 total cases (1.5%). Incomplete KD was more often seen in adolescents 
compared to children ≤ 10 years of age (59% vs. 29%). Some clinical features were more frequently seen in 
children than in adolescents, e.g. conjunctivitis (85% in ≤ 10 years of age vs. 65% in > 10 years), mucosal changes 
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(94% vs. 77%), rash (86% vs. 59%), and hand/foot changes (68% vs. 41%). While other clinical features were 
more often seen in adolescents, e.g., cervical lymphadenopathy (82% vs. 39%) and coronary dilatation (47% 
vs. 29%). Laboratory results (hemoglobin, leukocytes, erythrocyte sedimentation rate and C-reactive protein) 
did not differ much between the two groups. Conclusion: Kawasaki disease in adolescents has some different 
clinical profile from that of younger age. Majority of adolescent patients have incomplete presentation. Some 
clinical features such as conjunctivitis, mucosal changes, rash, and hand/foot changes are more often seen in 
children ≤ 10 years compared to in adolescents, while cervical lymphadenopathy and coronary dilatation are 
more frequently seen in adolescents. The ratio of male to female is much higher in adolescents.
Keywords: Kawasaki disease, adolescents.
INTRODUCTION
Kawasaki disease (KD) is an acute systemic 
vasculitis syndrome of unknown etiology that 
mainly affects infants and young children. 
KD was first reported by Tomisaku Kawasaki 
in 1967 in Japan.1 KD typically affects young 
children, mostly below 5 years of age with the 
highest incidence between 1-2 years of age.2 In 
Indonesia, it is estimated that over 2000 KD cases 
had been treated and presumably the majority 
of cases are still undiagnosed as the estimate 
incidence is approximately 5000 new cases per 
year.2 Coronary artery aneurysm develops in 15 
- 25% of untreated KD cases and may lead to 
myocardial infarction, sudden death, or ischemic 
heart disease.3
KD is extremely uncommon in patients 9 
years of age and older.4,5 The recent epidemiologic 
survey in Japan found that only 0.95% cases 
occurred in children 10 years of age and older.6 
The clinical criteria that establish the diagnosis 
of KD are the same in all age groups.7 Clinical 
findings at acute stage include fever persisting 
at least for 5 days, changes in the extremities 
(erythema of palms, soles, edema of hands, 
feet), polymorphous exanthema, bilateral 
conjunctival injection without exudate, changes 
in lips and oral cavity (erythema, strawberry 
tongue), unilateral cervical lymphadenopathy 
measuring >1.5 cm. Diagnosis of KD relies on 
the clinical presentation; laboratory tests are 
not specific, although anemia, leukocytosis, 
increased erythrocyte sedimentation rate, and 
increased C-reactive protein are frequently found 
on laboratory examination at acute stage. The 
diagnosis of KD may be missed in older children 
with fever of unknown origin.8
There is clearly a growing population of 
young adults with potentially important coronary 
artery disease after KD during childhood, and 
cardiologist must be prepared to take care for 
them.9 Antecedent KD should be considered in 
the evaluation of all cases of sudden, unexpected 
death in young adults.10 A history of Kawasaki-
like illness in childhood should be sought for 
adult patients presenting with coronary artery 
aneurysms in the absence of generalized 
atherosclerosis disease.11
As Kawasaki disease in adolescent and adult 
is rare and under-recognized, it is important to 
study data on patient presentations which may 
permit development of diagnostic criteria and 
treatment guidelines for this age group. We 
conducted this study to compare the clinical 
profile of  KD  between  adolescents ( ≥10 years) 
and children (<10 years).
METHODS
This is a cross-sectional study using a database 
of subjects with Kawasaki disease between 
January 2003 and December 2016 obtained from 
five hospitals in Jakarta and its surroundings (Cipto 
Mangunkusumo Hospital, Jakarta; Omni Hospital 
Alam Sutera, Tangsel; Harapan Kita Hospital, 
Jakarta; Siloam Hospital, Tangerang; Premier 
Bintaro Hospital, Tangsel). The choice of these 
hospitals was simply based on the author’s (NA) 
access. Variables studied were age, gender, clinical 
presentations (fever, conjunctivitis, mucosal 
changes, cervical lymphadenopathy, rash, hand/
foot changes), laboratory (hemoglobin, leukocyte, 
ESR, CRP) and echocardiogram (coronary 
artery dilatation). Diagnosis of KD was based on 
AHA (American Heart Association) consensus 
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criteria either for complete or incomplete cases.7 
The classic diagnosis of acute KD was based 
on fever persisting at least for 5 days, changes 
in the extremities (erythema of palms, soles, 
edema of hands, feet or peeling of fingers 
and toes at subacute stage), polymorphous 
exanthema, bilateral conjunctival injection 
without exudates, changes in lips and oral cavity 
(erythema, strawberry tongue), unilateral cervical 
lymphadenopathy measuring 1.5 cm or more. The 
presence of fever and ≥4 principal features allowed 
for the diagnosis of KD (complete KD). Patient 
with fever ≥5 days and <4 principal features was 
diagnosed as incomplete KD when coronary artery 
abnormality was detected by echocardiogram. 
For assessment of coronary artery dilatation, we 
used a Z score based on body surface area for 
right coronary artery (RCA), left main coronary 
artery (LMCA), and left anterior descending 
LAD.7 All echocardiographic examinations were 
done by the author (NA) at the time of diagnosis, 
at 2 weeks and then 6-8 weeks. Initial coronary 
dilatations are usually transient ones, but could 
be regarded as sequelae of KD if they persist 
beyond 30 days.12 Therefore, we determined the 
presence of coronary dilatation sequelae using the 
echocardiogram at >30 days.
Nearly all  (98%) patients received 
intravenous immunoglobulin (2g/kg BW) 
with high-dose (80-100 mg/kg BW) aspirin on 
admission according to the AHA consensus. 
Eligibility criteria were all patients regardless 
of age who met the AHA criteria for complete 
or incomplete Kawasaki disease with complete 
data of laboratory tests (hemoglobin, leukocytes, 
ESR and CRP) and echocardiogram.
Laboratory tests were done on admission. 
Anemia was considered as hemoglobin level 
below 10 g/dL. Leukocytosis was considered 
leukocyte count of over 15.000/mL, ESR increase 
as ≥40 mm /hour and increase of CRP as ≥30 
mg/L.7 This study has been approved by the Ethics 
Committee Faculty of Medicine Universitas 
Indonesia with a reference number 420A/PT02.
FK/ETIK/2012.
RESULTS
We found 1150 subjects with KD (age 1-192 
months) during the period of January 2003 to 
December 2016. Among them there were 17 
patients with age > 10 years (1.5%). While 
complete eligible data were obtained from 559 
subjects, 542 from ≤ 10 years and 17 from > 10 
years (adolescents).
In the adolescent group there were only 3 
females out of 17 subjects, with male to female 
ratio of nearly 4:1 while the ratio in the ≤ 10 
years group was around 1.5:1.
There was a difference between the two age 
groups in terms of the presence of mucosal changes 
(red lips and/or strawberry tongue) and rash which 
were less common in the adolescent group. On the 
other hand, cervical lymphadenopathy, incomplete 
KD and coronary artery dilatation were more 
commonly seen in the adolescent group.
DISCUSSION
Kawasaki disease is the most common 
cause of acquired heart disease in children in 
the developed countries. The majority of KD 
patients are below 5 years of age;2 there are few 
case reports of KD in adolescents and adults. 
Table 1. Characteristics of Kawasaki disease subjects
Characteristics of 
subjects
Age
≤ 10 years 
(n=542)
> 10 years 
(n=17)
Age (mo), Mean (SD) 27 (16) 135 (14)
Median (min-max) 24 (1-120) 134 (121-192)
Gender, n (%)
 - Male 330 (61) 14 (82)
 - Female 212 (39)  3 (18)
Clinical findings, n (%)
 - Fever 542 (100) 17 (100)
 - Conjunctivitis 462 (85) 11 (65)
 - Mucosal changes 509 (94) 13 (77)
 - Cervical 
lymphadenopathy
214 (39) 14 (82)
 - Rash 469 (86) 10 (59)
 - Hand/foot changes 367 (68) 7 (41)
Complete (%) 386 (71) 7 (41)
Laboratory results, n (%)
 - Anemia 103 (19) 4 (24)
 - Leukocytosis 299 (55) 7 (41)
 - ESR increase 406 (75) 15 (88)
 - CRP increase 412 (76) 14 (82)
Echocardiograpahy result, n (%) 
Coronary artery dilatation 159 (29) 8 (47)
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The diagnostic criteria for KD were developed 
for children and have not been validated in 
adolescents or adults. Fortunately, KD is 
uncommon in patients over 9 years of age.4,5
We reported 17 cases in adolescents (10-
16 years of age) out of 1150 total KD subjects 
(1.5%). This percentage is higher than that of 
survey in Japan which was 0.95% for subjects 
over 10 years of age, 6 but is likely lower than 
the findings of Momenah et al. which was 7.5% 
in children ≥9 years of age out of 133 total 
KD cases.8 We do not know the reason for the 
differences.
In the adolescents, there were just 3 females 
out of 17 subjects with the ratio of male to female 
was nearly 4:1. While in the ≤ 10 years subjects 
the ratio was 1.5:1. It seems that the male to 
female ratio is higher in adolescents compared 
to the younger ones. This result is in accordance 
with the study of Stockheim et al. which reported 
the ratio of male vs female KD ≥8 years was 
2.5:1.13 Momenah et al. reported the ratio of male 
vs female in ≥ 9 years of age 1:1.8 We could 
not explain the reason for this, whether it is by 
chance or any other reason.
 Incomplete cases were more frequently seen 
in adolescents (59% vs. 29%). The presence of 
coronary artery defects on echocardiogram can 
aid the diagnosis in those lacking the typical 
clinical features. As many cases of KD in 
adolescents have incomplete presentation, they 
might not be diagnosed until relatively late in 
their illness. This may lead to development 
of coronary aneurysms and cause long-term 
morbidity that may impair the quality of life, and 
although rare, mortality. It would be beneficial 
if there are specific diagnostic criteria in 
adolescents to avoid under-diagnosis. However, 
as the number of KD in adolescent is quite small, 
making specific diagnostic criteria for this age 
group would not be easy. In this study 5 out of 17 
adolescent cases (30%) were diagnosed after day 
10 of illness (delayed diagnosis). While in the ≤ 
10 years group 103 out of 542 subjects (19%) 
were diagnosed after day 10. It seems more 
difficult to diagnose KD in the adolescents as the 
majority of cases (60%) were incomplete type. 
So far there was no mortality until convalescence 
period in both groups. 
Our study showed that there were some 
differences in the clinical profile between the 
adolescents and the younger group. Some 
clinical features were more frequently seen in 
children ≤ 10 years than in adolescents such as 
conjunctivitis (85% in ≤ 10 years of age vs. 65% 
in > 10 years ), mucosal changes (94% vs. 77%), 
rash (86% vs. 59%), and hand/foot changes (68% 
vs. 41%). Stockheim et al.13 reported that fever, 
conjunctivitis and exanthem were observed 
with an equal rate in adults and children. 
Cervical lymphadenopathy was significantly 
more often seen in adolescent group (82% vs. 
39%) as also reported by Seve et al. in adults.14 
Likewise, coronary dilatation was more often 
seen in adolescents than in younger group. This 
is in line with the study of Momenah et al.8 but 
different from other studies which found that 
coronary aneurysms were seen more frequently 
in children.13,14 Laboratory results (hemoglobin, 
leukocytes, ESR and CRP level) did not differ 
much  between the two groups. It is rather hard 
to compare our results of the adolescent KD with 
other studies as there are very few studies and 
with very limited subjects.
The diagnosis of KD should be considered 
more often in adolescents and adults when 
patients present with fever, skin rash, and 
lymphadenopathy. As the main complication 
associated with KD is the development of 
coronary aneurysms which may cause long-term 
morbidity, awareness of the disease is essential 
to any physician either handling pediatric or 
adolescent patients. Once KD is diagnosed, 
immunoglobulin should be administered 
immediately to prevent the risk of coronary 
artery aneurysms.
CONCLUSION
Kawasaki disease can occur in adolescents 
with some different clinical profile than that of 
the classical findings of the disease in younger 
children. The ratio of male to female is much 
higher in adolescents and nearly 60% of them 
have incomplete presentations. Some clinical 
features are more often seen in children ≤10 years 
compared to adolescents such as conjunctivitis, 
mucosal changes, rash, and hand / foot changes. 
While cervical lymphadenopathy and coronary 
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artery dilatation were more frequently seen 
in adolescents. Physicians must be alert of 
the occurrence of KD in older children and 
adolescents or even adults to prevent coronary 
complications.
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